Even though the medical relevance from the aforementioned cardiovascular chance factor alterations by tirzepatide is going to be assessed during the planned cardiovascular end result review SURPASS-CVOT ( "variety":"medical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Asses